All Stories

  1. A Broadly Conserved Protective Epitope on the Lyme Disease Vaccine Antigen, OspA
  2. OspA Antibodies Inhibit the In vitro Transmigration of Borreliellia burgdorferi
  3. A Salmonella enterica serovar Typhimurium genome-wide CRISPRi screen reveals a role for type 1 fimbriae in evasion of antibody-mediated agglutination
  4. Inter-laboratory harmonization of microsphere immunoassays for SARS-CoV-2 antibody detection in contrived dried blood spots and oral fluids
  5. Maternal transfer of mRNA LNP-derived, pathogen-specific, monoclonal IgG to suckling mice
  6. A Refined Human Linear B Cell Epitope Map of Outer Surface Protein C (OspC) From the Lyme Disease Spirochete, Borrelia burgdorferi
  7. PfCSP-ferritin nanoparticle malaria vaccine antigen formulated with aluminum-salt and CpG 1018® adjuvants: Preformulation characterization, antigen-adjuvant interactions, and mouse immunogenicity studies
  8. ASalmonella entericaserovar Typhimurium Genome-wide CRISPRi Screen Reveals a Role for Type 1 Fimbriae in Evasion of Antibody-Mediated Agglutination
  9. Quantitating SARS-CoV-2 neutralizing antibodies from human dried blood spots
  10. A type-specific B cell epitope at the apex of Outer surface protein C (OspC) of the Lyme disease spirochete,Borreliella burgdorferi
  11. Antibody Profiles Elicited by Potent and Subpotent Whole Cell Pertussis Vaccines in Mice
  12. Inter-laboratory harmonization of microsphere immunoassays for SARS-CoV-2 antibody detection in dried blood spots and oral fluids
  13. A Biparatopic Intrabody Renders Vero Cells Impervious to Ricin Intoxication
  14. Structure of a Human Monoclonal Antibody in Complex with Outer Surface Protein C of the Lyme Disease Spirochete, Borreliella burgdorferi
  15. A Biparatopic Intrabody Renders Vero Cells Impervious to Ricin Intoxication
  16. Evaluating the Compatibility of New Recombinant Protein Antigens (Trivalent NRRV) with a Mock Pentavalent Combination Vaccine Containing Whole-Cell Pertussis: Analytical and Formulation Challenges
  17. A refined human linear B cell epitope map of Outer surface protein C (OspC) from the Lyme disease spirochete,Borreliella burgdorferi
  18. Inflammatory Profiles Induced by Intranasal Immunization with Ricin Toxin-immune Complexes
  19. Structure of a human monoclonal antibody in complex with Outer surface protein C (OspC) of the Lyme disease spirochete,Borreliella burgdorferi
  20. Single-domain antibodies reveal unique borrelicidal epitopes on the Lyme disease vaccine antigen, outer surface protein A (OspA)
  21. Quantitating SARS-CoV-2 Neutralizing Antibodies from Human Dried Blood Spots
  22. Demographic and Clinical Factors Associated With SARS-CoV-2 Spike 1 Antibody Response Among Vaccinated US Adults: the C4R Study
  23. Single-domain antibodies reveal unique borreliacidal epitopes on the Lyme disease vaccine antigen, Outer surface protein A (OspA)
  24. Clinical Assessment of SARS-CoV-2 Antibodies in Oral Fluids Following Infection and Vaccination
  25. The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of breakout workshops
  26. An mRNA-based platform for the delivery of pathogen-specific IgA into mucosal secretions
  27. Structural Basis of Antibody-Mediated Inhibition of Ricin Toxin Attachment to Host Cells
  28. Clinical Utility of SARS-CoV-2 Serological Testing and Defining a Correlate of Protection
  29. Inflammatory Profiles Induced following Intranasal Vaccination with Ricin Toxin-Immune Complexes
  30. Effects of aluminum-salt, CpG and emulsion adjuvants on the stability and immunogenicity of a virus-like particle displaying the SARS-CoV-2 receptor-binding domain (RBD)
  31. The SeroNet Clinical and Translational Serology Task Force (CTTF) SARS-CoV-2 mucosal immunity methodological considerations and best practices workshop
  32. An ancillary carbohydrate recognition domain on ricin toxin's B subunit is the target of receptor-blocking, neutralizing monoclonal antibodies
  33. Structure of a transmission blocking antibody in complex with Outer surface protein A from the Lyme disease spirochete, Borreliella burgdorferi
  34. Effects of aluminum-salt, CpG and emulsion adjuvants on the stability and immunogenicity of a virus-like particle displaying the SARS-CoV-2 receptor-binding domain (RBD)
  35. Nanoalum Formulations Containing Aluminum Hydroxide and CpG 1018TM Adjuvants: The Effect on Stability and Immunogenicity of a Recombinant SARS-CoV-2 RBD Antigen
  36. Flagellar-based motility accelerates IgA-mediated agglutination of Salmonella Typhimurium at high bacterial cell densities
  37. Structural Elucidation of a Protective B Cell Epitope on Outer Surface Protein C (OspC) of the Lyme Disease Spirochete, Borreliella burgdorferi
  38. mRNA delivery of dimeric human IgA protects mucosal tissues from bacterial infection
  39. An mRNA-Based Platform for the Delivery of Pathogen-Specific IgA into Mucosal Secretions
  40. Serum antibody profiling identifies vaccine-induced correlates of protection against aerosolized ricin toxin in rhesus macaques
  41. High-Throughput Epitope Mapping by Hydrogen Exchange-Mass Spectrometry
  42. Structural Elucidation of a Protective B cell Epitope on Outer Surface Protein C (OspC) of the Lyme disease spirochete,Borreliella burgdorferi
  43. Human B Cell Epitope Map of the Lyme Disease Vaccine Antigen, OspA
  44. Agglutination of Borreliella burgdorferi by Transmission-Blocking OspA Monoclonal Antibodies and Monovalent Fab Fragments
  45. Gut microbiome and breast-feeding: Implications for early immune development
  46. Serological Analysis Identifies Consequential B Cell Epitopes on the Flexible Linker and C-Terminus of Decorin Binding Protein A (DbpA) from Borrelia burgdorferi
  47. Transcytosis of IgA Attenuates Salmonella Invasion in Human Enteroids and Intestinal Organoids
  48. Antigen-adjuvant interactions, stability, and immunogenicity profiles of a SARS-CoV-2 receptor-binding domain (RBD) antigen formulated with aluminum salt and CpG adjuvants
  49. Durable Immunity to Ricin Toxin Elicited by Intranasally Administered Monoclonal Antibody–Based Immune Complexes
  50. Editorial: Mucosal Vaccination: Strategies to Induce and Evaluate Mucosal Immunity
  51. Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies
  52. Single-domain antibodies neutralize ricin toxin intracellularly by blocking access to ribosomal P-stalk proteins
  53. The Flexible Linker of Decorin Binding Protein A from Borrelia burgdorferi is a Target of Antibodies in Lyme disease
  54. Neutralization of Typhoid Toxin by Alpaca-Derived, Single-Domain Antibodies Targeting the PltB and CdtB Subunits
  55. Necroptosis of Lung Epithelial Cells Triggered by Ricin Toxin and Bystander Inflammation
  56. Single-Domain Antibodies for Intracellular Toxin Neutralization
  57. Durable Immunity to Ricin Toxin Elicited by a Thermostable, Lyophilized Subunit Vaccine
  58. Estimating Vaccine Potency Using Antibody-Based Competition Assays
  59. Salmonella Uptake into Gut-Associated Lymphoid Tissues: Implications for Targeted Mucosal Vaccine Design and Delivery
  60. Differential ER stress as a driver of cell fate following ricin toxin exposure
  61. Durable Immunity to Ricin Toxin Elicited by a Thermostable, Lyophilized Subunit Vaccine
  62. The prospect of orally administered monoclonal secretory IgA (SIgA) antibodies to prevent enteric bacterial infections
  63. The structural basis of Salmonella A2B5 toxin neutralization by antibodies targeting the glycan-receptor binding subunits
  64. Serological analysis reveals an imbalanced IgG subclass composition associated with COVID-19 disease severity
  65. Structural Analysis of Toxin-Neutralizing, Single-Domain Antibodies that Bridge Ricin’s A-B Subunit Interface
  66. Blocking Borrelia burgdorferi transmission from infected ticks to nonhuman primates with a human monoclonal antibody
  67. Mechanisms of typhoid toxin neutralization by antibodies targeting glycan receptor binding and nuclease subunits
  68. Recombinant Human Secretory IgA Induces Salmonella Typhimurium Agglutination and Limits Bacterial Invasion into Gut-Associated Lymphoid Tissues
  69. Slaying SARS-CoV-2 One (Single-domain) Antibody at a Time
  70. Mucoricin is a ricin-like toxin that is critical for the pathogenesis of mucormycosis
  71. Mucoricin is a Ricin-Like Toxin that is Critical for the Pathogenesis of Mucormycosis
  72. Sensitization of Airway Epithelial Cells to Toxin-Induced Death by TNF Superfamily Cytokines
  73. Sites of vulnerability on ricin B chain revealed through epitope mapping of toxin-neutralizing monoclonal antibodies
  74. Potency determination of ricin toxin using a monoclonal antibody-based competition assay
  75. Serological Analysis Reveals an Imbalanced IgG Subclass Composition Associated with COVID-19 Disease Severity
  76. Endpoint and epitope-specific antibody responses as correlates of vaccine-mediated protection of mice against ricin toxin
  77. Sites of Vulnerability on Ricin B Chain Revealed through Epitope Mapping of Toxin-Neutralizing Monoclonal Antibodies
  78. Transcriptional profiling of Vibrio cholerae O1 following exposure to human anti- lipopolysaccharide monoclonal antibodies
  79. Endpoint and Epitope-specific Antibody Responses as Correlates of Vaccine-mediated Protection of Mice against Ricin Toxin
  80. Passive Immunity to <em>Vibrio cholerae</em> O1 Afforded by a Human Monoclonal IgA1 Antibody Expressed in Milk
  81. The Factor H-Binding Site of CspZ as a Protective Target against Multistrain, Tick-Transmitted Lyme Disease
  82. A Humanized Monoclonal Antibody Cocktail to Prevent Pulmonary Ricin Intoxication
  83. Inhibition of invasive salmonella by orally administered IgA and IgG monoclonal antibodies
  84. Passive immunization with an extended half-life monoclonal antibody protects Rhesus macaques against aerosolized ricin toxin
  85. Intracellular Neutralization of Ricin Toxin by Single-domain Antibodies Targeting the Active Site
  86. Mechanisms of Typhoid Toxin Neutralization by Antibodies Targeting Receptor-Binding and Nuclease Subunits
  87. The Structural Basis of Salmonella A <sub>2</sub>B <sub>5</sub> Neutralization by Antibodies Targeting the Glycan-Receptor Binding Subunits
  88. An intranasally administered monoclonal antibody cocktail abrogates ricin toxin-induced pulmonary tissue damage and inflammation
  89. Intracellular Neutralization of Ricin Toxin by Single Domain Antibodies Targeting the Active Site Pocket
  90. Inhibition of Invasive Salmonella by Orally Administered IgA and IgG Monoclonal Antibodies
  91. TNF Family Cytokines Induce Distinct Cell Death Modalities in the A549 Human Lung Epithelial Cell Line when Administered in Combination with Ricin Toxin
  92. Sensitivity of Kupffer cells and liver sinusoidal endothelial cells to ricin toxin and ricin toxin–Ab complexes
  93. Rescue of rhesus macaques from the lethality of aerosolized ricin toxin
  94. A Collection of Single-Domain Antibodies that Crowd Ricin Toxin’s Active Site
  95. TRAIL (CD253) Sensitizes Human Airway Epithelial Cells to Toxin-Induced Cell Death
  96. A Humanized Monoclonal Antibody against the Enzymatic Subunit of Ricin Toxin Rescues Rhesus macaques from the Lethality of Aerosolized Ricin
  97. Biomedical Applications of Lumazine Synthase
  98. Thermal stability and epitope integrity of a lyophilized ricin toxin subunit vaccine
  99. Fine-Specificity Epitope Analysis Identifies Contact Points on Ricin Toxin Recognized by Protective Monoclonal Antibodies
  100. Contribution of an unusual CDR2 element of a single domain antibody in ricin toxin binding affinity and neutralizing activity
  101. Fine Specificity Epitope Analysis by HX-MS Identifies Contact Points on Ricin Toxin Recognized by Protective Monoclonal Antibodies
  102. TRAIL (CD253) Sensitizes Human Airway Epithelial Cells to Toxin-Induced Cell Death
  103. Alpha-galactosylceramide (αGalCer) enhances vaccine-induced protection in a model of ricin intoxication
  104. Vibrio cholerae O1 secretes an extracellular matrix in response to antibody-mediated agglutination
  105. A Supercluster of Neutralizing Epitopes at the Interface of Ricin’s Enzymatic (RTA) and Binding (RTB) Subunits
  106. High-Definition Mapping of Four Spatially Distinct Neutralizing Epitope Clusters on RiVax, a Candidate Ricin Toxin Subunit Vaccine
  107. High-Resolution Epitope Positioning of a Large Collection of Neutralizing and Nonneutralizing Single-Domain Antibodies on the Enzymatic and Binding Subunits of Ricin Toxin
  108. Evaluation of lumazine synthase from Bacillus anthracis as a presentation platform for polyvalent antigen display
  109. Using homology modeling to interrogate binding affinity in neutralization of ricin toxin by a family of single domain antibodies
  110. Spatial location of neutralizing and non-neutralizing B cell epitopes on domain 1 of ricin toxin’s binding subunit
  111. Structural analysis of single domain antibodies bound to a second neutralizing hot spot on ricin toxin's enzymatic subunit
  112. super-resolution
  113. A monoclonal antibody that targets the conserved core/lipid A region of lipopolysaccharide affects motility and reduces intestinal colonization of both classical and El Tor Vibrio cholerae biotypes
  114. A Novel Zak Knockout Mouse with a Defective Ribotoxic Stress Response
  115. Humanized Monoclonal Antibody That Passively Protects Mice against Systemic and Intranasal Ricin Toxin Challenge
  116. Structural analysis of nested neutralizing and non-neutralizing B cell epitopes on ricin toxin's enzymatic subunit
  117. A Bispecific Antibody Promotes Aggregation of Ricin Toxin on Cell Surfaces and Alters Dynamics of Toxin Internalization and Trafficking
  118. Novel Ricin Subunit Antigens With Enhanced Capacity to Elicit Toxin-Neutralizing Antibody Responses in Mice
  119. Enhancement of humoral immunity by the type II heat-labile enterotoxin LT-IIb is dependent upon IL-6 and neutrophils
  120. Progress and challenges associated with the development of ricin toxin subunit vaccines
  121. Neutralizing Monoclonal Antibodies against Disparate Epitopes on Ricin Toxin’s Enzymatic Subunit Interfere with Intracellular Toxin Transport
  122. Recent advances in the development of vaccines against ricin
  123. Role of Maternal Dietary Peanut Exposure in Development of Food Allergy and Oral Tolerance
  124. Sampling of Candida albicans and Candida tropicalis by Langerin-positive dendritic cells in mouse Peyer’s patches
  125. Comparative Adjuvant Effects of Type II Heat-Labile Enterotoxins in Combination with Two Different Candidate Ricin Toxin Vaccine Antigens
  126. Mechanisms of Ricin Toxin Neutralization Revealed through Engineered Homodimeric and Heterodimeric Camelid Antibodies
  127. Plant-based production of two chimeric monoclonal IgG antibodies directed against immunodominant epitopes of Vibrio cholerae lipopolysaccharide
  128. Phenotypic Analysis of a Population of IgA+ Cells in the Follicle-Associated Epithelium of Mouse Peyer's Patches
  129. Thermostable ricin vaccine protects rhesus macaques against aerosolized ricin: Epitope-specific neutralizing antibodies correlate with protection
  130. Rapid Effects of a Protective O-Polysaccharide-Specific Monoclonal IgA on Vibrio cholerae Agglutination, Motility, and Surface Morphology
  131. Glassy-State Stabilization of a Dominant Negative Inhibitor Anthrax Vaccine Containing Aluminum Hydroxide and Glycopyranoside Lipid A Adjuvants
  132. Combination of two candidate subunit vaccine antigens elicits protective immunity to ricin and anthrax toxin in mice
  133. Biological Activities of IgA
  134. A tripartite cocktail of chimeric monoclonal antibodies passively protects mice against ricin, staphylococcal enterotoxin B and Clostridium perfringens epsilon toxin
  135. Oral Interleukin-10 Alleviates Polyposis via Neutralization of Pathogenic T-Regulatory Cells
  136. Crystal Structures of Ricin Toxin's Enzymatic Subunit (RTA) in Complex with Neutralizing and Non-Neutralizing Single-Chain Antibodies
  137. Mice Deficient in Intestinal Epithelium Cytochrome P450 Reductase are Prone to Acute Toxin-induced Mucosal Damage
  138. Differential Neutralizing Activities of a Single Domain Camelid Antibody (VHH) Specific for Ricin Toxin’s Binding Subunit (RTB)
  139. Antibody-Mediated Inhibition of Ricin Toxin Retrograde Transport
  140. A Population of Langerin-Positive Dendritic Cells in Murine Peyer's Patches Involved in Sampling β-Glucan Microparticles
  141. Localization of non-linear neutralizing B cell epitopes on ricin toxin's enzymatic subunit (RTA)
  142. Chimeric Plantibody Passively Protects Mice against Aerosolized Ricin Challenge
  143. Stepwise Engineering of Heterodimeric Single Domain Camelid VHH Antibodies That Passively Protect Mice from Ricin Toxin
  144. Three-Dimensional Reconstruction of Murine Peyer's Patches from Immunostained Cryosections
  145. Biophysical characterization and immunization studies of dominant negative inhibitor (DNI), a candidate anthrax toxin subunit vaccine
  146. Stabilization of a recombinant ricin toxin A subunit vaccine through lyophilization
  147. Neutralizing monoclonal antibodies against ricin's enzymatic subunit interfere with protein disulfide isomerase-mediated reduction of ricin holotoxin in vitro
  148. Neutralizing activity and protective immunity to ricin toxin conferred by B subunit (RTB)-specific Fab fragments
  149. LT-IIb(T13I), a Non-Toxic Type II Heat-Labile Enterotoxin, Augments the Capacity of a Ricin Toxin Subunit Vaccine to Evoke Neutralizing Antibodies and Protective Immunity
  150. Effect of single-point mutations on the stability and immunogenicity of a recombinant ricin A chain subunit vaccine antigen
  151. Comparative Efficacy of Two Leading Candidate Ricin Toxin A Subunit Vaccines in Mice
  152. High‐Throughput, Cell‐Based Screens to Identify Small‐Molecule Inhibitors of Ricin Toxin and Related Category B Ribosome Inactivating Proteins (RIPs)
  153. Exposure of Salmonella enterica Serovar Typhimurium to a Protective Monoclonal IgA Triggers Exopolysaccharide Production via a Diguanylate Cyclase-Dependent Pathway
  154. Identification of Small Molecules That Suppress Ricin-Induced Stress-Activated Signaling Pathways
  155. Resolution of two overlapping neutralizing B cell epitopes within a solvent exposed, immunodominant α-helix in ricin toxin's enzymatic subunit
  156. FRUIT, a Scar-Free System for Targeted Chromosomal Mutagenesis, Epitope Tagging, and Promoter Replacement in Escherichia coli and Salmonella enterica
  157. Sub-Domains of Ricin’s B Subunit as Targets of Toxin Neutralizing and Non-Neutralizing Monoclonal Antibodies
  158. Association of a Protective Monoclonal IgA with the O Antigen of Salmonella enterica Serovar Typhimurium Impacts Type 3 Secretion and Outer Membrane Integrity
  159. Plant-based expression of a partially humanized neutralizing monoclonal IgG directed against an immunodominant epitope on the ricin toxin A subunit
  160. Rediscovering IgA
  161. Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut
  162. Protective immunity to ricin toxin conferred by antibodies against the toxin's binding subunit (RTB)
  163. Role of the Mannose Receptor (CD206) in Innate Immunity to Ricin Toxin
  164. Transient Suppression of Shigella flexneri Type 3 Secretion by a Protective O-Antigen-Specific Monoclonal IgA
  165. Vaccine-induced intestinal immunity to ricin toxin in the absence of secretory IgA
  166. Small-Molecule Inhibitors of Ricin and Shiga Toxins
  167. Mucosal Vaccines for Biodefense
  168. Immunity to Ricin: Fundamental Insights into Toxin–Antibody Interactions
  169. Folding domains within the ricin toxin A subunit as targets of protective antibodies
  170. Identification of small-molecule inhibitors of ricin and shiga toxin using a cell-based high-throughput screen
  171. Identification of new classes of ricin toxin inhibitors by virtual screening
  172. Recognition of secretory IgA by DC-SIGN: Implications for immune surveillance in the intestine
  173. Secretory IgA: Arresting Microbial Pathogens at Epithelial Borders
  174. A Monoclonal Immunoglobulin G Antibody Directed against an Immunodominant Linear Epitope on the Ricin A Chain Confers Systemic and Mucosal Immunity to Ricin
  175. Neutralizing Monoclonal Antibodies Directed against Defined Linear Epitopes on Domain 4 of Anthrax Protective Antigen
  176. RicinA Type II Ribosome-Inactivating Protein
  177. Inhibition of Salmonella enterica Serovar Typhimurium Motility and Entry into Epithelial Cells by a Protective Antilipopolysaccharide Monoclonal Immunoglobulin A Antibody
  178. Evidence for Widespread Epithelial Damage and Coincident Production of Monocyte Chemotactic Protein 1 in a Murine Model of Intestinal Ricin Intoxication
  179. IgA and Antigen Sampling
  180. Characterization of a Novel High-Affinity Monoclonal Immunoglobulin G Antibody against the Ricin B Subunit
  181. Immunoglobulin A Antibodies against Ricin A and B Subunits Protect Epithelial Cells from Ricin Intoxication
  182. Ricin induces IL-8 secretion from human monocyte/macrophages by activating the p38 MAP kinase pathway
  183. Vaccines against the category B toxins: Staphylococcal enterotoxin B, epsilon toxin and ricin
  184. Analysis of Adhesion Molecules Involved in Leukocyte Homing into the Basolateral Pockets of Mouse Peyer's Patch M Cells
  185. The Viral σ1 Protein and Glycoconjugates Containing α2-3-Linked Sialic Acid Are Involved in Type 1 Reovirus Adherence to M Cell Apical Surfaces
  186. Collaboration of epithelial cells with organized mucosal lymphoid tissues
  187. Immunization of mice with recombinant gp41 in a systemic prime/mucosal boost protocol induces HIV-1-specific serum IgG and secretory IgA antibodies
  188. Immunization of mice with peptomers covalently coupled to aluminum oxide nanoparticles
  189. The composition and function of M cell apical membranes: Implications for microbial pathogenesis
  190. The
  191. Host recognition by the VirA, VirG two-component regulatory proteins of Agrobacterium tumefaciens
  192. The Intestinal Epithelium: The Interface Between Host and Pathogen